A new alliance aims to develop new improved imaging techniques and robotics, to detect early tumours and pre-cancerous lesions.
News
CHMP approves first Ebola vaccine, six other medicines
The committee accepted seven medicines and rejected two. It also granted four indication extensions, and withdrew three applications for new medicines.
QiC Diabetes awards 2019 results announced
The award programme recognises work of NHS teams and individuals.
56% rise in GPs seeking mental health help in last year
As a results, NHS Practitioner Health plans to recruit around 40 additional clinicians and grow its therapist network.
BMS, Pfizer turn to Fitbit for atrial fibrillation detection
AFib is the most common type of irregular heartbeat and is a significant risk factor for stroke.
Xofluza bags FDA approval for flu complications
The drug is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from the flu.
CHMP U-turn for Evenity
The approval is for severe osteoporosis in postmenopausal women at high risk of fracture.
NICE ‘ok’ for Bayer’s Xarelto
The drug is an anticoagulant that targets Factor Xa, approved to prevent atherothrombotic events in coronary artery disease.
Clinigen launches programme to provide Azedra outside US
The Progenics drug is currently not approved for any indication outside of the US.
Chiesi announces two successful sets of asthma data
24% of asthma patients have difficult-to-treat or severe versions of the disease.
Genetic Parkinson’s cohorts ‘urgently’ need identifying
Only half of patients who are diagnosed as young onset patients are offered a genetic test on diagnosis.
Gov awards urgent meds freight contracts
UPS, DFDS and Biocair will handle express freight services to deliver medicines and medical products within 24 to 48 hours in the event of a no-deal Brexit.
AZ/Daiichi’s breast cancer drug gets US priority review
AstraZeneca and Daiichi Sankyo’s trastuzumab deruxtecan has taken a step closer to US approval having been accepted for priority review by the US Food and Drug Administration (FDA) for breast cancer.
Just two weeks left until MSEA closes for entry!
The 2019 Medical & Scientific Excellence Awards will be closing for entry on 31st October.
Obesity levels of four and five-year-olds rose 9.5% last year
58,000 more children were recorded as obese than last year.
